Food and Drug Administration |
|
21 CFR 573.460(a)(1)(i) |
AAFCO Publication |
2003 |
Official Publication
|
Association of American Feed Control Officials, Inc. |
Food and Drug Administration |
|
21 CFR 522.2640(a) |
FDA Publication |
2012 |
Determination of Factor Content in Tylosin by High Performance Liquid Chromatography
|
Food and Drug Administration, U.S. Department of Health and Human Services |
Food and Drug Administration |
|
21 CFR 522.2640(a) |
FDA Publication |
2001 |
Determination of Factor Content in Tylosin by High Performance Liquid Chromatography
|
Food and Drug Administration, U.S. Department of Health and Human Services |
Health and Human Services Department |
89 FR 51738 |
21 CFR 514 |
ISO 9000 |
2015 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 514 |
ISO 13485 |
2016 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 7496 |
21 CFR 4 |
ISO 13485:2016(E) |
2016 |
Medical Devices; Quality System Regulation Amendments
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 4 |
ISO 9000 |
2015 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 4 |
ISO 13485 |
2016 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 7496 |
21 CFR 4 |
ISO 9000:2015(E), Clause 3 |
2015 |
Medical Devices; Quality System Regulation Amendments
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 314 |
ISO 13485 |
2016 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 314 |
ISO 9000 |
2015 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Food and Drug Administration |
|
21 CFR 299.4(d) |
USAN and the USP Dictionary of Drug Names |
1985 |
Guiding Principles for Coining U.S. Adopted Names for Drugs
|
U.S. Pharmacopeial Convention |
Food and Drug Administration |
|
21 CFR 26.60(b) |
ISO Guide 2 |
1996 |
Standardization and Related Activities-General Vocabulary of the ISO and IEC
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 230 |
ISO 9000 |
2015 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 230 |
ISO 13485 |
2016 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 213 |
ISO 9000 |
2015 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Food and Drug Administration |
|
21 CFR 211.176 |
FDA Publication |
1989 |
Procedures for Detecting and Measuring Penicillin Contamination in Drugs
|
Food and Drug Administration, U.S. Department of Health and Human Services |
Food and Drug Administration |
|
21 CFR 211.176 |
FDA Publication |
2012 |
Procedures for Detecting and Measuring Penicillin Contamination in Drugs
|
Food and Drug Administration, U.S. Department of Health and Human Services |
Health and Human Services Department |
89 FR 51738 |
21 CFR 211 |
ISO 13485 |
2016 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 211 |
ISO 9000 |
2015 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 210 |
ISO 9000 |
2015 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 210 |
ISO 13485 |
2016 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Food and Drug Administration |
|
21 CFR 201.327(i)(1)(iv) |
ISO 17166 CIE S007/E |
2000 |
Erythemal reference action spectrum and standard erythema dose
|
International Organization for Standardization |
Food and Drug Administration |
|
21 CFR 201.327(i)(1)(ii)(C) |
ISO 17166 CIE S007/E |
2000 |
Erythemal reference action spectrum and standard erythema dose
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 201 |
ISO 9000 |
2015 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Health and Human Services Department |
89 FR 51738 |
21 CFR 201 |
ISO 13485 |
2016 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases
|
International Organization for Standardization |
Food and Drug Administration |
|
21 CFR 2.19 |
AOAC Official Methods |
1980 |
Official Methods of Analysis and Supplements
|
AOAC International |
Food and Drug Administration |
|
21 CFR 189.5(a)(6) |
AOAC Method Ca 3a-46 |
1997 |
Insoluble Impurities
|
AOAC International |
Food and Drug Administration |
|
21 CFR 189.190(c) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 189.180(c) |
AOAC Journal |
1971 |
Gas Chromatographic Determination of Safrole and Related in Nonalcoholic Beverages: Collaborative, Vol. 54, No. 4, pages 900-902
|
AOAC International |
Food and Drug Administration |
|
21 CFR 189.175(c) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 189.165(c) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 189.155(c) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 189.145(c) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 189.135(c) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 189.130(c) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 189.110(c) |
AOAC Journal |
1973 |
Flavors and Nonalcoholic Beverages, Vol. 56, No. 5, pages 1281-1283
|
AOAC International |
Food and Drug Administration |
|
21 CFR 184.1985(b) |
Food Chemicals Codex |
1981 |
Aminopeptidase Enzyme Preparation Derived from Lactococcus Lactis
|
National Academy Press |
Food and Drug Administration |
|
21 CFR 184.1979c(b)(2) |
Food Chemicals Codex |
1996 |
Whey Protein Concentrate
|
National Academy Press |
Food and Drug Administration |
|
21 CFR 184.1979c(b)(1) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 184.1979b(b)(2) |
Food Chemicals Codex |
1996 |
Reduced Minerals Whey
|
National Academy Press |
Food and Drug Administration |
|
21 CFR 184.1979b(b)(1) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 184.1979a(b)(2) |
Food Chemicals Codex |
1996 |
Reduced Lactose Whey
|
National Academy Press |
Food and Drug Administration |
|
21 CFR 184.1979a(b)(1) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 184.1979(b)(2) |
Food Chemicals Codex |
1996 |
Whey
|
National Academy Press |
Food and Drug Administration |
|
21 CFR 184.1979(b)(1) |
AOAC Official Methods |
1980 |
Official Methods of Analysis
|
AOAC International |
Food and Drug Administration |
|
21 CFR 184.1978(b) |
Food Chemicals Codex |
1981 |
Carnauba Wax
|
National Academy Press |
Food and Drug Administration |
|
21 CFR 184.1976(b) |
Food Chemicals Codex |
1981 |
Candelilla Wax
|
National Academy Press |
Food and Drug Administration |
|
21 CFR 184.1973(b) |
Food Chemicals Codex |
1981 |
Beeswax (Yellow and White)
|
National Academy Press |
Food and Drug Administration |
|
21 CFR 184.1950(b) |
Food Chemicals Codex |
1981 |
Vitamin D
|
National Academy Press |